US2009104694A1PendingUtilityA1
Isolation and transplantation of retinal stem cells
Est. expiryFeb 11, 2020(expired)· nominal 20-yr term from priority
A61P 31/00A61P 29/00A01K 67/0271C12N 5/0623C12N 2501/135C12N 2501/115C12N 5/0621C12N 2506/02C12N 2501/11A61P 27/02A61K 35/12
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to the isolation, in vitro propagation, and transplantation and integration of non-pigmented retinal stem cells derived from the neuroretina of the eye, ex vivo and in vivo.
Claims
exact text as granted — not AI-modified1 . Retinal stem cells isolated from a neuroretina of a donor mammal.
2 . Retinal stem cells isolated from a neuroretina of a donor mammal, being capable of:
a) self-renewal in vitro; b) differentiating into any one cell type of the group consisting of neurons, astrocytes, and oligodendrocytes; c) integration into a host retina when grafted on the host retina; and d) differentiation into photoreceptor cells when grafted onto a retina, onto a retinal explants, or into a mature eye.
3 . The retinal stem cells of claim 1 or 2 , wherein the retinal stem cells express nestin and are non-pigmented.
4 . The retinal stem cells of claim 1 or 2 , said cells requiring, when cultured in vitro, the presence at least one exogenous growth factor in a culture medium in order to proliferate.
5 . The retinal stem cells of claim 4 , wherein at least one exogenous growth factor is a member selected from the group consisting of epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), a combination of bFGF and EGF, and a combination of EGF and bFGF and platelet-derived growth factor (PDGF).
6 . The retinal stem cells of claim 1 or 2 , which can differentiate into neurons, as evidenced by expression of a neurofilament protein, NF-200.
7 . The retinal stem cells of claim 1 or 2 , which can differentiate into astrocytes, as evidenced by expression of glial fibrillary acidic protein, GFAP.
8 . The retinal stem cells of claim 1 or 2 , which, when grafted onto a retina, onto a retinal explants, or into a mature eye, differentiate into photoreceptor cells expressing rhodopsin, recoverin, or both.
9 . The retinal stem cells of claim 8 , further being capable of integrating into and repopulating a diseased retina.
10 . The retinal stem cells of claim 1 or 2 , wherein the mammal is an embryo, a neonate, or an adult.
11 . The retinal stem cells of claim 1 or 2 , wherein the mammal is a primate, a rodent, or a domesticated animal.
12 . The retinal stem cells of claim 1 or 2 , wherein the mammal is a human, a mouse, a rat, a cat, a dog, a pig, a cow, a horse, a monkey, or a great ape.
13 - 24 . (canceled)
25 . The neuroretina-derived retinal stem cells of claim 1 or 2 , wherein the mammal was is a transgenic mouse expressing green fluorescent protein.
26 . The neuroretina-derived retinal stem cells of claim 1 or 2 , being clonally derived.
27 - 45 . (canceled)
46 . The retinal stem cells of claim 1 which are derived from a neurosphere.Join the waitlist — get patent alerts
Track US2009104694A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.